<p>Hinge Health Inc.（紐約證券交易所代碼：HNGE - 獲取免費報告）在 12 月份的空頭頭寸顯著增加。截至 12 月 15 日，空頭頭寸總計為 4,180,660 股，比 11 月 30 日的 1,922,965 股增加了 117.4%。根據平均每日交易量 1,473,836 股，目前的覆蓋天數比率為 2.8 天。大約 5.3% 的公司股份被做空。</p>
<h2>Hinge Health 的內部活動</h2>
<p>在相關消息中，首席執行官 Daniel Antonio Perez 於 12 月 15 日星期一出售了 166,670 股公司的股票，交易價格為每股平均 48.53 美元，總價值為 8,088,495.10 美元。該交易在向 SEC 的法律文件中披露，相關文件可通過此鏈接獲取。此外，首席財務官 James Budge 於 11 月 25 日星期二出售了 44,589 股公司的股票，交易價格為每股平均 47.47 美元，總價值為 2,116,639.83 美元。出售後，首席財務官直接持有 479,878 股公司的股票，估值約為 22,779,808.66 美元。此交易代表其持股減少了 8.50%。該銷售的 SEC 文件提供了更多信息。在過去三個月中，內部人士共出售了價值 120,486,691 美元的 2,638,440 股公司股票。</p>
<h2>機構投資者對 Hinge Health 的看法</h2>
<p>大型投資者最近調整了對公司的持股。Sandler Capital Management 在第三季度將其在 Hinge Health 的股份增加了 1.4%。Sandler Capital Management 目前持有 52,728 股公司的股票，價值 2,588,000 美元，此前在上個季度購買了 728 股。Mirae Asset Global Investments Co. Ltd.在第三季度購買了 Hinge Health 的新股份，價值約 37,000 美元。Montag A &amp; Associates Inc.在第二季度獲得了 Hinge Health 的新頭寸，價值約 41,000 美元。Jones Financial Companies Lllp 在第三季度將其在 Hinge Health 的持股增加了 348.0%。Jones Financial Companies Lllp 目前持有 1,120 股公司的股票，估值 54,000 美元，此前在上個季度增加了 870 股。最後，SBI Securities Co. Ltd.在第二季度獲得了 Hinge Health 的新股份，價值約 48,000 美元。</p>
<h2>分析師的升級與降級</h2>
<p>多家研究公司最近對 HNGE 發表了看法。華爾街 Zen 在 12 月 20 日星期六的報告中將 Hinge Health 的評級從 “持有” 上調至 “買入”。Weiss Ratings 在 10 月 8 日星期三的研究報告中重申了對 Hinge Health 股票的 “賣出（d）” 評級。Evercore ISI 在 10 月 8 日星期三的研究報告中將 Hinge Health 的目標價格從 60.00 美元提高至 65.00 美元，並給予公司 “跑贏大盤” 的評級。Baird R W 在 9 月 5 日星期五的研究報告中將 Hinge Health 的評級提升至 “持有”。最後，巴克萊在 11 月 5 日星期三的報告中將 Hinge Health 的目標價格從 62.00 美元提高至 65.00 美元，並給予公司 “增持” 的評級。一位股票研究分析師給予該股票 “強烈買入” 評級，十五位給予 “買入” 評級，兩位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat.com 的數據，Hinge Health 的共識評級為 “適度買入”，共識目標價格為 59.93 美元。</p>
<p><strong>獲取我們關於 HNGE 的最新研究報告</strong></p>
<h2>Hinge Health 的價格表現</h2>
<p>紐約證券交易所 HNGE 在星期五開盤價為 47.57 美元。該公司的 50 日簡單移動平均線為 47.59 美元，200 日簡單移動平均線為 49.34 美元。Hinge Health 的年內最低價為 33.42 美元，年內最高價為 62.18 美元。</p>
<p>Hinge Health（紐約證券交易所代碼：HNGE - 獲取免費報告）最後一次發佈季度財報是在 11 月 4 日星期二。公司報告季度每股收益為（0.02 美元），超出分析師共識預期的（0.20 美元）0.18 美元。公司季度收入為 1.5421 億美元，而分析師預期為 1.4244 億美元。該公司的季度收入同比增長 53.3%。</p>
<p>Hinge Health 宣佈其董事會於 11 月 12 日星期三授權了一項股票回購計劃，允許公司回購價值 2.5 億美元的流通股份。該回購授權允許公司通過公開市場購買最多 7.2% 的股票。股票回購計劃通常表明公司董事會認為其股票被低估。</p>
<h2>Hinge Health 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Hinge Health（紐約證券交易所代碼：HNGE）是一家數字肌肉骨骼（MSK）診所，提供預防和管理肌肉骨骼疾病的端到端解決方案。公司的平台結合了可穿戴運動傳感器、由持證物理治療師指導的個性化運動療法和行為健康輔導，以提供量身定製的治療計劃。通過將技術與基於證據的臨牀協議相結合，Hinge Health 旨在減輕疼痛、改善活動能力並減少對更具侵入性干預（如手術或阿片類藥物處方）的依賴。</p>
<p>Hinge Health 成立於 2015 年，總部位於舊金山，與僱主、健康計劃和其他支付方合作，提供其自我導向的應用程序基礎項目。</p>
<h2>相關文章</h2>
<ul>
<li>我們更看好的五隻股票比 Hinge Health 更好</li>
<li>請勿刪除，立即閲讀</li>
<li>投資者警報：微型 “3 美元 AI 奇蹟股票” 即將爆發</li>
<li>資本利得税是否可以扣除任何費用？</li>
<li>你知道亞馬遜計劃在 1 月 1 日做什麼嗎？</li>
<li>巴菲特、蓋茨和貝索斯悄悄拋售股票——原因在這裏</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Hinge Health 嗎？</h2>
<p>在考慮 Hinge Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前購買……而 Hinge Health 並不在名單上。</p>
<p>雖然 Hinge Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

HNGE

<p>Hinge Health Inc.（紐約證券交易所代碼：HNGE）在 12 月份的空頭頭寸增加了 117.4%，總計達到 4,180,660 股。覆蓋天數比率為 2.8 天。首席執行官 Daniel Perez 和首席財務官 James Budge 最近出售了大量股份。機構投資者調整了他們的持股，其中一些增加了持股比例。分析師的評級意見不一，普遍共識為 “適度買入”，目標價為 59.93 美元。該股票開盤價為 47.57 美元，50 日均線為 47.59 美元，200 日均線為 49.34 美元</p>

<p>Hinge Health Inc. (NYSE:HNGE - Get Free Report) was the recipient of a significant increase in short interest in December. As of December 15th, there was short interest totaling 4,180,660 shares, an increase of 117.4% from the November 30th total of 1,922,965 shares. Based on an average daily trading volume, of 1,473,836 shares, the days-to-cover ratio is presently 2.8 days. Approximately 5.3% of the company's shares are short sold. Approximately 5.3% of the company's shares are short sold. Based on an average daily trading volume, of 1,473,836 shares, the days-to-cover ratio is presently 2.8 days.</p>
<div class="lb-trans"><p>Hinge Health Inc.（紐約證券交易所代碼：HNGE - 獲取免費報告）在 12 月份的空頭頭寸顯著增加。截至 12 月 15 日，空頭頭寸總計為 4,180,660 股，比 11 月 30 日的 1,922,965 股增加了 117.4%。根據平均每日交易量 1,473,836 股，目前的覆蓋天數比率為 2.8 天。大約 5.3% 的公司股份被做空。</p>
</div><h2>Insider Activity at Hinge Health</h2>
<div class="lb-trans"><h2>Hinge Health 的內部活動</h2>
</div><p>In related news, CEO Daniel Antonio Perez sold 166,670 shares of the company's stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $48.53, for a total value of $8,088,495.10. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO James Budge sold 44,589 shares of the firm's stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $47.47, for a total value of $2,116,639.83. Following the sale, the chief financial officer directly owned 479,878 shares of the company's stock, valued at approximately $22,779,808.66. This trade represents a 8.50% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 2,638,440 shares of company stock valued at $120,486,691 in the last three months.</p>
<div class="lb-trans"><p>在相關消息中，首席執行官 Daniel Antonio Perez 於 12 月 15 日星期一出售了 166,670 股公司的股票，交易價格為每股平均 48.53 美元，總價值為 8,088,495.10 美元。該交易在向 SEC 的法律文件中披露，相關文件可通過此鏈接獲取。此外，首席財務官 James Budge 於 11 月 25 日星期二出售了 44,589 股公司的股票，交易價格為每股平均 47.47 美元，總價值為 2,116,639.83 美元。出售後，首席財務官直接持有 479,878 股公司的股票，估值約為 22,779,808.66 美元。此交易代表其持股減少了 8.50%。該銷售的 SEC 文件提供了更多信息。在過去三個月中，內部人士共出售了價值 120,486,691 美元的 2,638,440 股公司股票。</p>
</div><h2>Institutional Investors Weigh In On Hinge Health</h2>
<div class="lb-trans"><h2>機構投資者對 Hinge Health 的看法</h2>
</div><p>Large investors have recently modified their holdings of the company. Sandler Capital Management grew its stake in shares of Hinge Health by 1.4% during the third quarter. Sandler Capital Management now owns 52,728 shares of the company's stock worth $2,588,000 after purchasing an additional 728 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Hinge Health during the 3rd quarter worth about $37,000. Montag A &amp; Associates Inc. acquired a new position in shares of Hinge Health during the 2nd quarter worth about $41,000. Jones Financial Companies Lllp increased its holdings in shares of Hinge Health by 348.0% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company's stock valued at $54,000 after acquiring an additional 870 shares during the last quarter. Finally, SBI Securities Co. Ltd. acquired a new stake in shares of Hinge Health during the 2nd quarter worth about $48,000.</p>
<div class="lb-trans"><p>大型投資者最近調整了對公司的持股。Sandler Capital Management 在第三季度將其在 Hinge Health 的股份增加了 1.4%。Sandler Capital Management 目前持有 52,728 股公司的股票，價值 2,588,000 美元，此前在上個季度購買了 728 股。Mirae Asset Global Investments Co. Ltd.在第三季度購買了 Hinge Health 的新股份，價值約 37,000 美元。Montag A &amp; Associates Inc.在第二季度獲得了 Hinge Health 的新頭寸，價值約 41,000 美元。Jones Financial Companies Lllp 在第三季度將其在 Hinge Health 的持股增加了 348.0%。Jones Financial Companies Lllp 目前持有 1,120 股公司的股票，估值 54,000 美元，此前在上個季度增加了 870 股。最後，SBI Securities Co. Ltd.在第二季度獲得了 Hinge Health 的新股份，價值約 48,000 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師的升級與降級</h2>
</div><p>A number of research firms have recently weighed in on HNGE. Wall Street Zen upgraded Hinge Health from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, December 20th. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Hinge Health in a research report on Wednesday, October 8th. Evercore ISI boosted their price target on shares of Hinge Health from $60.00 to $65.00 and gave the company an &#34;outperform&#34; rating in a research note on Wednesday, October 8th. Baird R W raised shares of Hinge Health to a &#34;hold&#34; rating in a research report on Friday, September 5th. Finally, Barclays lifted their target price on shares of Hinge Health from $62.00 to $65.00 and gave the company an &#34;overweight&#34; rating in a report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Hinge Health has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $59.93.</p>
<div class="lb-trans"><p>多家研究公司最近對 HNGE 發表了看法。華爾街 Zen 在 12 月 20 日星期六的報告中將 Hinge Health 的評級從 “持有” 上調至 “買入”。Weiss Ratings 在 10 月 8 日星期三的研究報告中重申了對 Hinge Health 股票的 “賣出（d）” 評級。Evercore ISI 在 10 月 8 日星期三的研究報告中將 Hinge Health 的目標價格從 60.00 美元提高至 65.00 美元，並給予公司 “跑贏大盤” 的評級。Baird R W 在 9 月 5 日星期五的研究報告中將 Hinge Health 的評級提升至 “持有”。最後，巴克萊在 11 月 5 日星期三的報告中將 Hinge Health 的目標價格從 62.00 美元提高至 65.00 美元，並給予公司 “增持” 的評級。一位股票研究分析師給予該股票 “強烈買入” 評級，十五位給予 “買入” 評級，兩位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat.com 的數據，Hinge Health 的共識評級為 “適度買入”，共識目標價格為 59.93 美元。</p>
</div><p><strong>Get Our Latest Research Report on HNGE</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 HNGE 的最新研究報告</strong></p>
</div><h2>Hinge Health Price Performance</h2>
<div class="lb-trans"><h2>Hinge Health 的價格表現</h2>
</div><p>NYSE HNGE opened at $47.57 on Friday. The firm has a 50 day simple moving average of $47.59 and a 200-day simple moving average of $49.34. Hinge Health has a one year low of $33.42 and a one year high of $62.18.</p>
<div class="lb-trans"><p>紐約證券交易所 HNGE 在星期五開盤價為 47.57 美元。該公司的 50 日簡單移動平均線為 47.59 美元，200 日簡單移動平均線為 49.34 美元。Hinge Health 的年內最低價為 33.42 美元，年內最高價為 62.18 美元。</p>
</div><p>Hinge Health (NYSE:HNGE - Get Free Report) last posted its quarterly earnings data on Tuesday, November 4th. The company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.20) by $0.18. The company had revenue of $154.21 million for the quarter, compared to analysts' expectations of $142.44 million. The firm's quarterly revenue was up 53.3% compared to the same quarter last year.</p>
<div class="lb-trans"><p>Hinge Health（紐約證券交易所代碼：HNGE - 獲取免費報告）最後一次發佈季度財報是在 11 月 4 日星期二。公司報告季度每股收益為（0.02 美元），超出分析師共識預期的（0.20 美元）0.18 美元。公司季度收入為 1.5421 億美元，而分析師預期為 1.4244 億美元。該公司的季度收入同比增長 53.3%。</p>
</div><p>Hinge Health announced that its board has authorized a share buyback program on Wednesday, November 12th that permits the company to buyback $250.00 million in outstanding shares. This buyback authorization permits the company to purchase up to 7.2% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's board believes its shares are undervalued.</p>
<div class="lb-trans"><p>Hinge Health 宣佈其董事會於 11 月 12 日星期三授權了一項股票回購計劃，允許公司回購價值 2.5 億美元的流通股份。該回購授權允許公司通過公開市場購買最多 7.2% 的股票。股票回購計劃通常表明公司董事會認為其股票被低估。</p>
</div><h2>Hinge Health Company Profile</h2>
<div class="lb-trans"><h2>Hinge Health 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Hinge Health NYSE: HNGE is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.</p>
<div class="lb-trans"><p>Hinge Health（紐約證券交易所代碼：HNGE）是一家數字肌肉骨骼（MSK）診所，提供預防和管理肌肉骨骼疾病的端到端解決方案。公司的平台結合了可穿戴運動傳感器、由持證物理治療師指導的個性化運動療法和行為健康輔導，以提供量身定製的治療計劃。通過將技術與基於證據的臨牀協議相結合，Hinge Health 旨在減輕疼痛、改善活動能力並減少對更具侵入性干預（如手術或阿片類藥物處方）的依賴。</p>
</div><p>Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.</p>
<div class="lb-trans"><p>Hinge Health 成立於 2015 年，總部位於舊金山，與僱主、健康計劃和其他支付方合作，提供其自我導向的應用程序基礎項目。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>相關文章</h2>
</div><ul>
<li>Five stocks we like better than Hinge Health</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Do you know what Amazon is planning for January 1?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Hinge Health 更好</li>
<li>請勿刪除，立即閲讀</li>
<li>投資者警報：微型 “3 美元 AI 奇蹟股票” 即將爆發</li>
<li>資本利得税是否可以扣除任何費用？</li>
<li>你知道亞馬遜計劃在 1 月 1 日做什麼嗎？</li>
<li>巴菲特、蓋茨和貝索斯悄悄拋售股票——原因在這裏</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Hinge Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Hinge Health 嗎？</h2>
</div><p>Before you consider Hinge Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Hinge Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前購買……而 Hinge Health 並不在名單上。</p>
</div><p>While Hinge Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Hinge Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Hinge Health Inc. (NYSE:HNGE) 的空頭頭寸更新